Supporting Breast Cancer Patients and Providers Through Treatment and Survivorship: Implementation and Usability Evaluation of the MyJourney Platform (Preprint)
Notice bibliographique
Résumé
<sec> <title>BACKGROUND</title> Breast cancer is the most common cancer among Canadian women, bringing complex demands for timely decision-making, coordination of multidisciplinary care, and efficient communication between patients and providers. The increasing reliance on fragmented and non-interoperable health information systems exacerbates workflow and documentation burdens, leading to inefficiencies and gaps in continuity of care. While nurse navigation programs partially bridge these gaps, most digital platforms remain poorly integrated into provider workflows, requiring manual tracking, which results in duplicated effort and reduced efficiency. Our team developed ‘MyJourney’ at North York General Hospital in Ontario. It is a digital navigation platform that supports breast cancer care throughout the entire continuum, from diagnosis to survivorship. </sec> <sec> <title>OBJECTIVE</title> This study aimed to (1) map the breast cancer journey and workflow to inform the design and adaptation of MyJourney at two oncology settings at NYGH; (2) identify barriers and guide local implementation; and (3) evaluate the implementation, usability, and perceived utility of MyJourney's Clinical Navigation Tool for breast cancer care teams. </sec> <sec> <title>METHODS</title> A multi-method, three-phase study was conducted at NYGH’s Breast Diagnostic Centre (BDC) and Chemotherapy Clinic in Toronto, Canada. Phase 1 involved qualitative interviews with breast cancer patients to map their care journey and inform user-centered platform design. Phase 2 included pre-implementation interviews with nurses, pharmacists, and administrative staff to map workflows and customize MyJourney for the chemotherapy clinic. Phase 3 evaluated MyJourney’s implementation and usability over six weeks using the System Usability Scale, Technology Acceptance Model surveys, and follow-up interviews with platform users. Data were analyzed via interpretive description and descriptive statistics. Ethics approval was obtained. </sec> <sec> <title>RESULTS</title> 13 patient interviews revealed distinct challenges and communication needs across pre-diagnosis, diagnosis, treatment, and survivorship phases, emphasizing the need for personalized, integrated resources. Eight providers and clinic staff highlighted pain points in fragmented information systems, inefficient manual processes, and limited team coordination. MyJourney’s phased implementation led to high user acceptance, with mean System Usability Scale scores rated “excellent” (BDC: 81.3; Chemotherapy Clinic: 86.3 at six-week follow-up). Users described the platform as intuitive, efficient, and well-organized, citing consolidated patient records, streamlined appointment management, and improved workflow as major benefits. Recommendations included improved interoperability, enhanced notifications, role-specific customization, and integration with electronic medical records for broader scalability. </sec> <sec> <title>CONCLUSIONS</title> The iterative, stakeholder-engaged design and phased implementation of MyJourney facilitated rapid uptake and high usability among breast cancer provider teams. The Clinical Navigation Tool component of the MyJourney platform reduced documentation burden, improved workflow efficiency, and facilitated care coordination across oncology settings. </sec>
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,002 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».